In the fast-paced finance world, being ahead is crucial. After a busy September with over 10 mainboard IPOs, October promises more exciting investment opportunities.
This article is here to give you a sneak peek at the new companies going public in October 2023. It will help you make smart money choices and handle your finances wisely.
Tata Technologies: Engineering the Future
Tata Technologies Limited, a significant player within the automotive design sector under the Tata Motors group, provides a diverse range of global engineering, research, and development services. With a global presence spanning 27 countries, the market eagerly anticipates information about the company’s upcoming IPO, including the IPO date and the price range.
EbixCash Limited: Redefining Digital Solutions
EbixCash Limited, headquartered in Noida, is a technology-driven company that excels in delivering digital products and services across various domains, including B2C, B2B, and fintech. It has established a robust presence in payment solutions, travel, financial technology, and BPO services, positioning itself to have a significant impact in these sectors.
The forthcoming IPO is anticipated to raise approximately ₹6,000 crore, making it one of the most substantial offerings in recent memory. Investors interested in the fintech and digital sectors may find this IPO particularly appealing. However, important details regarding the IPO, such as the price range and dates, have not been disclosed yet.
Balaji Speciality Chemicals
Established in 2010, Balaji Specialty Chemicals, a subsidiary of Balaji Amines Limited (BAL), has gained renown for its manufacturing of ethylamine, methylamines, pharma excipients, and specialty chemical derivatives. The company plays a significant role in various industries, such as pharmaceuticals and agrochemicals.
Located in Solapur, Maharashtra, Balaji Specialty Chemicals Limited is preparing to launch an Initial Public Offering (IPO) with an estimated size of approximately ₹425 crore.
The company’s clientele includes Nanjing Union Chemical Company Limited, Korea India Limited, UPL Limited, Dr. Reddy’s Laboratories Limited, and Aarti Drugs Limited.
SPC Life Sciences
SPC Life Sciences Limited has received approval from SEBI to launch its IPO in June 2023. The company specializes in manufacturing and supplying advanced intermediates for critical active pharmaceutical ingredients, particularly in therapeutic areas like cardiovascular vasodilators (anti-platelets), anti-psychotics, and anti-depressants.
According to the company’s Draft Red Herring Prospectus (DRHP), the IPO is expected to include a fresh issue valued at Rs. 300 crores, along with 89.39 lakh equity shares offered for sale by the promoter, Mr. Snehal Rajivbhai Patel. The SPC Life Sciences IPO is anticipated to be introduced to the market in the last week of October 2023. Other details are not yet known.
We are back with our On-Demand “ZERO TO HERO” Trading Strategy Webinar. Click Here To Register!
Disclaimer: The information provided in this Blog is for educational purposes only and should not be construed as financial advice. Trading in the stock market involves a significant level of risk and can result in both profits and losses. Spider Software & Team does not guarantee any specific outcome or profit from the use of the information provided in this Blog. It is the sole responsibility of the viewer to evaluate their own financial situation and to make their own decisions regarding any investments or trading strategies based on their individual financial goals, risk tolerance, and investment objectives. Spider Software & Team shall not be liable for any loss or damage, including without limitation any indirect, special, incidental or consequential loss or damage, arising from or in connection with the use of this blog or any information contained herein.
